<VariationArchive VariationID="2951625" VariationName="NM_004586.3(RPS6KA3):c.2093dup (p.Val699fs)" VariationType="Duplication" Accession="VCV002951625" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3114473" VariationID="2951625">
      <GeneList>
        <Gene Symbol="RPS6KA3" FullName="ribosomal protein S6 kinase A3" GeneID="6197" HGNC_ID="HGNC:10432" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="20149911" stop="20267097" display_start="20149911" display_stop="20267097" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="20168028" stop="20284749" display_start="20168028" display_stop="20284749" Strand="-" />
          </Location>
          <OMIM>300075</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS6KA3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RPS6KA3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004586.3(RPS6KA3):c.2093dup (p.Val699fs)</Name>
      <CanonicalSPDI>NC_000023.11:20156115:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="20156115" stop="20156116" display_start="20156115" display_stop="20156116" variantLength="1" positionVCF="20156115" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="20174233" stop="20174234" display_start="20174233" display_stop="20174234" variantLength="1" positionVCF="20174233" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>V699fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.20174234dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.20174234dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.20156116dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.20156116dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007488.1" sequenceAccession="NG_007488" sequenceVersion="1" change="g.115517dup">
            <Expression>NG_007488.1:g.115517dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004586.3" sequenceAccession="NM_004586" sequenceVersion="3" change="c.2093dup" MANESelect="true">
            <Expression>NM_004586.3:c.2093dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004577.1" sequenceAccession="NP_004577" sequenceVersion="1" change="p.Val699fs">
            <Expression>NP_004577.1:p.Val699fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004586.3(RPS6KA3):c.2093dup (p.Val699fs) AND multiple conditions" Accession="RCV003812312" Version="1">
        <ClassifiedConditionList TraitSetID="10232">
          <ClassifiedCondition DB="MedGen" ID="C0265252">Coffin-Lowry syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0796225">Intellectual disability, X-linked 19</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16879200</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30740391</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10232" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10895" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, X-linked 19</ElementValue>
                <XRef ID="MONDO:0010447" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 19</ElementValue>
                <XRef Type="MIM" ID="300844" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300075.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300075.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300075.0020" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XLID19</ElementValue>
                <XRef Type="MIM" ID="300844" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22687" />
                <XRef ID="22687" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301520</ID>
                <ID Source="BookShelf">NBK1346</ID>
              </Citation>
              <XRef ID="777" DB="Orphanet" />
              <XRef ID="C0796225" DB="MedGen" />
              <XRef ID="MONDO:0010447" DB="MONDO" />
              <XRef Type="MIM" ID="300844" DB="OMIM" />
            </Trait>
            <Trait ID="823" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Coffin-Lowry syndrome</ElementValue>
                <XRef ID="Coffin-Lowry+Syndrome/1709" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010561" DB="MONDO" />
                <XRef ID="15182000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation with osteocartilaginous abnormalities</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Coffin syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COFFIN-LOWRY SYNDROME, MILD</ElementValue>
                <XRef Type="Allelic variant" ID="300075.0011" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLS</ElementValue>
                <XRef Type="MIM" ID="303600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Coffin-Lowry syndrome (CLS) is usually characterized by severe-to-profound intellectual disability in males; less severely impaired individuals have been reported. Neuropsychiatric concerns can include behavioral problems, loss of strength, progressive spasticity or paraplegia, sleep apnea, or stroke. Stimulus-induced drop attacks (SIDAs) in which unexpected tactile or auditory stimuli or excitement triggers a brief collapse but no loss of consciousness are present in approximately 20% of affected individuals. Typically SIDAs begin between mid-childhood and the teens. Characteristic facial features may be more apparent with age. Upper-extremity differences may be subtle and include short, soft, fleshy hands with tapered fingers as well as fleshy forearms. Progressive kyphoscoliosis is one of the most difficult aspects of long-term care. Affected females tend to have intellectual disability in the mild-to-moderate range and may also have the typical facial, hand, and skeletal findings noted in males.</Attribute>
                <XRef ID="NBK1346" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6123" />
                <XRef ID="6123" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301520</ID>
                <ID Source="BookShelf">NBK1346</ID>
              </Citation>
              <XRef ID="192" DB="Orphanet" />
              <XRef ID="C0265252" DB="MedGen" />
              <XRef ID="MONDO:0010561" DB="MONDO" />
              <XRef Type="MIM" ID="303600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8563350" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="27345974|MedGen:C0265252;C0796225" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004607030" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16879200</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30740391</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val699Serfs*15) in the RPS6KA3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 42 amino acid(s) of the RPS6KA3 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RPS6KA3-related conditions. This variant disrupts a region of the RPS6KA3 protein in which other variant(s) (p.Arg729Trp) have been determined to be pathogenic (PMID: 16879200, 30740391). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPS6KA3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.20174233_20174234insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265252" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796225" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8563350" TraitType="Disease" MappingType="XRef" MappingValue="C0265252" MappingRef="MedGen">
        <MedGen CUI="C0265252" Name="Coffin-Lowry syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8563350" TraitType="Disease" MappingType="XRef" MappingValue="C0796225" MappingRef="MedGen">
        <MedGen CUI="C0796225" Name="Intellectual disability, X-linked 19" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

